Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Welcome
Go
Free Newsletter Sign Up

FDA Shortens Interval for Moderna Covid Booster to 5 Months (1)

Jan. 7, 2022, 5:29 PM

U.S. regulators amended the emergency authorization for Moderna Inc.’s Covid-19 vaccine to allow Americans to get a booster shot five months after receiving the initial first two shots.

The decision by the Food and Drug Administration echoes a similar move it made earlier this week to reduce the recommended interval between the second and third doses of the Pfizer Inc.-BioNTech SE vaccine for all adults to five months. The Centers for Disease Control and Prevention also added its recommendation to the timeline.

“Now all Americans who are age 18 and above should get a booster with Moderna at ...